Success Metrics

Clinical Success Rate
40.0%

Based on 2 completed trials

Completion Rate
40%(2/5)
Active Trials
6(38%)
Results Posted
100%(2 trials)
Terminated
3(19%)

Phase Distribution

Ph phase_1
1
6%
Ph phase_2
3
19%
Ph early_phase_1
2
13%
Ph not_applicable
8
50%

Phase Distribution

3

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution14 total trials
Early Phase 1First-in-human
2(14.3%)
Phase 1Safety & dosage
1(7.1%)
Phase 2Efficacy & side effects
3(21.4%)
N/ANon-phased studies
8(57.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

28.6%

2 of 7 finished

Non-Completion Rate

71.4%

5 ended early

Currently Active

6

trials recruiting

Total Trials

16

all time

Status Distribution
Active(7)
Completed(2)
Terminated(5)
Other(2)

Detailed Status

Recruiting5
Terminated3
unknown2
Completed2
Withdrawn2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
6
Success Rate
40.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 12 (14.3%)
Phase 11 (7.1%)
Phase 23 (21.4%)
N/A8 (57.1%)

Trials by Status

unknown213%
not_yet_recruiting16%
terminated319%
completed213%
active_not_recruiting16%
withdrawn213%
recruiting531%

Recent Activity

6 active trials
Showing 5 of 16
active_not_recruitingnot_applicable

Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer

NCT03697148
terminated

MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation

NCT05087888
not_yet_recruitingnot_applicable

Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer

NCT07468903
completednot_applicable

Prostate Resection After Microwave Ablation (PRAMA)

NCT06128525
withdrawnphase_2

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

NCT04910425
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT03697148Not Applicable

Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer

Active Not Recruiting
NCT05087888

MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation

Terminated
NCT07468903Not Applicable

Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer

Not Yet Recruiting
NCT06128525Not Applicable

Prostate Resection After Microwave Ablation (PRAMA)

Completed
NCT04910425Phase 2

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

Withdrawn
NCT05438563Not Applicable

MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer

Recruiting
NCT06067269Phase 2

Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial

Recruiting
NCT06865768Phase 2

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique

Recruiting
NCT05852041Early Phase 1

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

Recruiting
NCT04752267Early Phase 1

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

Completed
NCT02809690Phase 1

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

Terminated
NCT03514927Not Applicable

High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer

Withdrawn
NCT02501759Not Applicable

Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer

Terminated
NCT03849482

Multiparametric Magnetic Resonance Imaging Versus Fine Needle Aspiration Cytology for Parotid Gland Neoplasms

Unknown
NCT01194648Not Applicable

Focal Therapy for Prostate Cancer Using HIFU

Recruiting
NCT01292291Not Applicable

MRI in Diagnosing Prostate Cancer

Unknown

All 16 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
16